Vioxx Deal Yields Lawyer Payday

Law360, New York (November 9, 2007, 12:00 AM EST) -- The settlement reached in the Vioxx product liability litigation has been touted as a victory for both plaintiffs and drug maker Merck & Co. Inc. But the deal also means a major payday for a third party: the plaintiffs attorneys.

The terms of Merck & Co. Inc.'s $4.85 billion settlement, disclosed on Friday, stipulate that 85% of plaintiffs with pending or tolled claims must opt into the settlement process in order for the deal to go through. If the requisite number of plaintiffs do not initiate...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.